4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001214659-20-002736
Chief Technical Officer sold 3,750 shares at $19.19 ($71,980)
From the SEC's structured data for this filing
Trades in this filing
MOORE ALISON · Chief Technical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-03-16 | Sale : show line 1 in the form | −3,750 | $19.19 | $71,980 | 63,021 | D |
| Open-market sales · 3,750 sh · avg $19.19 · $71,980 | ||||||
Loading xslF345X03/marketforms-48347.xml…